FDA-cleared profile

HeartFocus

Deski · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.

Clinical role
Real-time probe guidance, diagnostic-quality view detection, automatic clip recording and retrospective best-effort recording.
Images and patients
Ultrasound · Heart/Cardiovascular
Key limitation
Keep in mind: Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart/Cardiovascular Input: Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.
  • Who uses it?Intended users: Medical professionals trained in ultrasound basics and HeartFocus using DESKi training or approved materials delivered by a trained medical professional.
  • What does the software produce?Output: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.
  • What is its most important limitation?Key limitation: Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.

Clinical takeaway. Clinical role: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.

Evidence takeaway. Evidence from the reviewed source record: The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Real-time probe guidance, diagnostic-quality view detection, automatic clip recording and retrospective best-effort recording.
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Prescription cardiac ultrasound examinations using a compatible general-purpose diagnostic ultrasound system.
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Medical professionals trained in ultrasound basics and HeartFocus using DESKi training or approved materials delivered by a trained medical professional.
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.
  • Exact FDA submission
  • Checked 2026-09-05
Evidence summary
The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

The reviewed exact-release summary reports acquisition and quality metrics, not a disease-detection sensitivity with an applicable clinical endpoint.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

A disease-detection specificity for HeartFocus v1.3.0 was not established by the reviewed summary.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

HeartFocus v1.3.0 Special 510(k) verification and validation

  • DesignSimulated-use usability evaluation and historical-image AI validation, with software and cybersecurity verification.
  • PopulationEight representative novice medical professionals with basic ultrasound training in a simulated iPhone/iQ3 workflow; separate historical validation used 40 US and 40 non-US patients.
  • Scopeexact submission
  • Tested versionHeartFocus v1.3.0
  • IndependenceIndependence not established

K260780

No new clinical investigation for K260780. The historical-image cohort is distinct from the eight-participant usability evaluation; no diagnostic-outcome metric is inferred.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Pricing is recorded, but no exact-product procurement price with a stated offer scope is published in the reviewed sources.

Public pricing
The current HeartFocus pricing page lists $695 per license/year/probe or $1,800 per license/three years/probe for up to five licenses, with unlimited users. Enterprise plans for six or more licenses require a custom quote.
  • Product family
  • Checked 2026-09-06

The page uses a dollar symbol without an ISO currency designation and does not identify v1.3.0. This is a current family offer, not an exact-version quote; structured prices remain empty pending currency and contract confirmation.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · HeartFocus v1.3.0: K260780 clearance and 510(k) summary

  2. Routing

    Source context, not route validation: Receives an ultrasound image stream and supports exam transfer using DICOM protocols.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · HeartFocus v1.3.0: K260780 clearance and 510(k) summary

  3. AI processing

    Source context, not route validation: The application performs its acquisition functions offline and stores medical data locally on the mobile device; the summary states that these data are not sent to a DESKi-controlled server. The change supports iPhone with iOS 17 or later, an A12 Bionic CPU and a minimum 4.7-inch display.

    Scope: Exact FDA submission. This describes the cleared application boundary, not every connected PACS or enterprise export configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · HeartFocus v1.3.0: K260780 clearance and 510(k) summary

  4. Returned objects

    Source context, not route validation: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · HeartFocus v1.3.0: K260780 clearance and 510(k) summary

  5. Viewer/worklist/report

    Unresolved route: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · HeartFocus v1.3.0: K260780 clearance and 510(k) summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The application performs its acquisition functions offline and stores medical data locally on the mobile device; the summary states that these data are not sent to a DESKi-controlled server. The change supports iPhone with iOS 17 or later, an A12 Bionic CPU and a minimum 4.7-inch display.
  • Exact FDA submission
  • Checked 2026-09-05

This describes the cleared application boundary, not every connected PACS or enterprise export configuration.

Integration
Receives an ultrasound image stream and supports exam transfer using DICOM protocols.
  • Exact FDA submission
  • Checked 2026-09-05
Security
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, provides security researcher prerequisites (no patient-safety risk, written permission before testing, coordinated public disclosure timing), an encrypted reporting channel (security@deski.ai with a public PGP key), and handling expectations for vulnerability reports.
  • Vendor-wide
  • Checked 2026-10-27

Vendor CVD policy naming DESKi on the HeartFocus product site (heartfocus.ai), which uses the deski.ai contact domain. Exact-release scope is not established.

Training
Ultrasound basics and product training are required, provided by DESKi or a trained medical professional using approved materials.
  • Exact FDA submission
  • Checked 2026-09-05
Monitoring
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, states acknowledgement of receipt within two business days, investigation and risk analysis of reported vulnerabilities, and a summary of findings provided to the submitter.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The policy names DESKi products and services generally and does not scope these commitments to any specific product release; exact-release scope is not established. This is an intake and response-handling commitment; it states no uptime, drift or continuous-monitoring claims.

Current family connectivity requirements

The vendor FAQ describes offline scanning, online license verification every 30 days, and network access for installation, updates and DICOM export.

product family · checked 2026-09-05

Current public family documentation is not explicitly version-linked to K260780.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260780
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-03
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
18Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored title PROSPECTIVE EVALUATION OF HEARTFOCUS and DESKi sponsor support a product-family lead. Exact tested version and registry results require full-record review; no trial performance promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, vendor pricing observation, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Deski HeartFocus reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

9 sources - 3 history items

Source ledger

  1. K260780 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. HeartFocus v1.3.0: K260780 clearance and 510(k) summary

    US Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinical, implementation, evidence

  7. HeartFocus frequently asked questions

    DESKi / HeartFocus - Accessed 2026-09-05

    Scope: product_family_implementation, pricing_limitations

  8. HeartFocus pricing plans

    DESKi / HeartFocus - Accessed 2026-09-06

    Scope: product_family_pricing

  9. DESKi: Coordinated Vulnerability Disclosure

    DESKi - Accessed 2026-10-27

    Scope: security

Research history

  1. K260780 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K253535

Ligence Heart

Ligence Uab

Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-02-27
FDA-cleared K252235

PVAD IQ Software

Ultrasight, Ltd.

Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2025-12-18
FDA-cleared K242807

HeartFocus (V.1.1.1)

Deski

Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2025-04-04

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history